Oncopeptides AB

Career Opportunities

Oncopeptides is a global biotech company striving to attract, retain and develop some of the most talented people in industry.

Open Positions

Pay attention to that the links below are to external websites. They are beyond the control of Oncopeptides AB (publ) and are not covered by our privacy policy.

If you want to be part of Oncopeptides, please submit your resume to Career@oncopeptides.com for future considerations.

Oncopeptides does not have the capabilities to handle unsolicited resumes from third-party recruiters or staffing agencies.

Open positions in Europe, click on the link:

International Commercial Manager - Stockholm, Sweden

January 8, 2024
We are looking for an ambitious person with a strong drive and a will to succeed to fill the new position as International Commercial Manager. In this position you will be a key player in the global marketing department at Oncopeptides at a very exciting time in the history of the company.
Read more

Compliance Director - Stockholm, Sweden

January 8, 2024
In this role you will be responsible for implementing the Company’s compliance program, including development of policies and procedures throughout Europe. This position will be responsible for reducing and managing the risk of violating laws, regulations and internal policies when commercializing our drug Pepaxti.
Read more

Medical Science Liaison (MSL) – Italy

October 6, 2023
The Medical Science Liaison (MSL) acts as Oncopeptides first point of contact in the field for external stakeholders, including key opinion leaders (KOL), hemato-oncologists in the hospital, pharmacists, and nurses. The role will provide continuous medical updates and scientific information/education on Oncopeptides’ products and relevant indications, position and differentiate Melflufen within the Multiple Myeloma treatment landscape and contribute to the development and execution of Oncopeptides’ overall company strategy, e.g., by continuously seeking for HCP’s feedback, needs & requirements, and project ideas - and for relevant insights from the overall hematology treatment landscape.
Read more